[HTML][HTML] Characteristics of people seeking prescribed cannabinoids for the treatment of chronic pain: evidence from project twenty 21

…, B Brandner, B Haja, E Iveson… - Frontiers in Pain …, 2022 - frontiersin.org
Background: Prescribed cannabinoids are now legal in the UK and increasingly being used
for a variety of conditions, with one of the most frequent conditions being chronic pain. This …

[HTML][HTML] Cannabis-based medicinal products (CBMPs) for the treatment of Long COVID symptoms: current and potential applications

H Thurgur, AK Schlag, E Iveson… - Exploration of …, 2023 - explorationpub.com
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection can result in a
range of persistent symptoms impacting everyday functioning for a considerable proportion …

Feasibility of a cannabidiol‐dominant cannabis‐based medicinal product for the treatment of long COVID symptoms: A single‐arm open‐label feasibility trial

…, AK Schlag, C Croser, DJ Nutt, E Iveson - British Journal of …, 2024 - Wiley Online Library
Aims To conduct a single‐arm open‐label feasibility trial of the safety and tolerability of a full‐
spectrum cannabidiol (CBD)‐dominant cannabis‐based medicinal product for treating the …

The role of inheritance and environment in predisposition to vascular disease in people of African descent

L Kalra, C Rambaran, E Iveson, PJ Chowienczyk… - Journal of the American …, 2006 - jacc.org
Objectives: This study sought to compare vascular reactivity and carotid intima media
thickness (CIMT) between Afro-Caribbean people in the United Kingdom (UK) and the West …

The under use of thromboprophylaxis in older medical in-patients: a regional audit

A South, E Iveson, V Allgar… - QJM: An International …, 2007 - academic.oup.com
Background: The risk of venous thromboembolism (VTE) among medical in-patients
increases with age. Thromboprophylaxis using low-molecular-weight heparin can reduce …

An international matched cohort study of the contribution of metabolic impairments to subclinical atherosclerosis in United Kingdom and Jamaican African-Caribbeans

L Kalra, E Iveson, C Rambaran, R Sherwood… - Atherosclerosis, 2008 - Elsevier
BACKGROUND: A gradient of increased vascular risk exists across the African diaspora. We
hypothesised that increased insulin resistance with environmental transition contributes to …

[HTML][HTML] An unusual exacerbation of chronic obstructive pulmonary disease (COPD) with herpes simplex tracheitis: case report

AC Boland, EH Iveson, MW Elliott - Journal of Medical Case Reports, 2007 - Springer
Chronic obstructive pulmonary disease (COPD) is a common cause of morbidity in the UK
and is increasingly seen in elderly patients, often requiring multiple courses of steroids. We …

[PDF][PDF] Does vitamin D deficiency predispose to post stroke fatigue

K Njoku, E Iveson - Ir Med J, 2020 - imj.ie
Vitamin D Deficiency and Post-stroke Fatigue amongst Ambulant Stroke Survivors:
Experience of an Acute Stroke Centre Page 1 Issue: Ir Med J; Vol 113; No. 2; P23 Does …

Homocysteine, migration and early vascular impairment in people of African descent

L Kalra, E Iveson, C Rambaran, R Sherwood… - Heart, 2008 - heart.bmj.com
Objectives: A gradient of increased vascular risk with migration exists across the African
diaspora. We investigated the hypothesis that differences in homocysteine/folic acid status …

Feasibility of a cannabidiol (CBD)-dominant cannabis-based medicinal product (CBMP) for the treatment of Long COVID symptoms: A single arm open-label feasibility …

…, AK Schlag, C Croser, DJ Nutt, E Iveson - British Journal of …, 2023 - europepmc.org
Aims To conduct a single arm open-label feasibility trial of the safety and tolerability of a full-
spectrum cannabidiol (CBD)-dominant cannabis-based medicinal product (CBMP) for …